Literature DB >> 7928235

Magnetoferritin. Biomineralization as a novel molecular approach in the design of iron-oxide-based magnetic resonance contrast agents.

J W Bulte1, T Douglas, S Mann, R B Frankel, B M Moskowitz, R A Brooks, C D Baumgarner, J Vymazal, J A Frank.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7928235

Source DB:  PubMed          Journal:  Invest Radiol        ISSN： 0020-9996            Impact factor:   6.016


× No keyword cloud information.
  4 in total

Review 1.  MRI-detectable nanoparticles: the potential role in the diagnosis of and therapy for chronic kidney disease.

Authors:  Jennifer R Charlton; Scott C Beeman; Kevin M Bennett
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

2.  Disruptive chemical doping in a ferritin-based iron oxide nanoparticle to decrease r2 and enhance detection with T1-weighted MRI.

Authors:  M Veronica Clavijo Jordan; Scott C Beeman; Edwin J Baldelomar; Kevin M Bennett
Journal:  Contrast Media Mol Imaging       Date:  2014-04-25       Impact factor: 3.161

3.  Biocompatibility of ferritin-based nanoparticles as targeted MRI contrast agents.

Authors:  Jennifer R Charlton; Valeria M Pearl; Anna R Denotti; Jonathan B Lee; Sundararaman Swaminathan; Yogesh M Scindia; Nathan P Charlton; Edwin J Baldelomar; Scott C Beeman; Kevin M Bennett
Journal:  Nanomedicine       Date:  2016-04-09       Impact factor: 5.307

Review 4.  New imaging tools to measure nephron number in vivo: opportunities for developmental nephrology.

Authors:  K M Bennett; E J Baldelomar; D Morozov; R L Chevalier; J R Charlton
Journal:  J Dev Orig Health Dis       Date:  2020-01-27       Impact factor: 2.401
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.